Skip to main content
Aaron Rosenberg, MD, Oncology, Sacramento, CA, University of California, Davis Medical Center

AaronRosenbergMD

Oncology Sacramento, CA

Hematologic Oncology

Assistant Professor of Medicine

Dr. Rosenberg is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Rosenberg's full profile

Already have an account?

Education & Training

  • Tufts Medical Center
    Tufts Medical CenterFellowship, Hematology and Medical Oncology, 2010
  • Temple University Hospital
    Temple University HospitalResidency, Internal Medicine, 2007 - 2009
  • Temple University Hospital
    Temple University HospitalInternship, Internal Medicine, 2006 - 2007
  • Icahn School of Medicine at Mount Sinai
    Icahn School of Medicine at Mount SinaiClass of 2006
  • Wesleyan University
    Wesleyan UniversityBA, 1997 - 2001

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2014 - 2024
  • MA State Medical License
    MA State Medical License 2010 - 2015
  • PA State Medical License
    PA State Medical License 2006 - 2010
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Association Between Autologous Stem Cell Transplant and Survival Among Californians with Multiple Myeloma  
    Aaron S Rosenberg, Brian A Jonas, Journal of the National Cancer Institute

Abstracts/Posters

  • Blinatumomab/Lenalidomide in Relapsed/Refractory Non-HodgkinÍs Lymphoma: A Phase I California Cancer Consortium Study of Safety, Efficacy and Immune Correlative Analysis
    Aaron Seth Rosenberg, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Phase I Study of Escalating Doses of Carfilzomib with Hyper-CVAD in Patients with Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma
    Aaron Seth Rosenberg, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Professional Memberships

Hospital Affiliations